Texas Sues Merck For Medicaid Fraud, Cites Vioxx Advertising
This article was originally published in The Pink Sheet Daily
Executive Summary
Lawsuit filed under the state’s Medicaid Fraud Prevention Act alleges Merck misrepresented the safety of the COX-2 inhibitor through advertising campaigns and “direct representations” to the Texas Medicaid program. Attorney General’s office is seeking $168 mil. in damages, three times the amount Texas Medicaid paid for Vioxx scripts.